Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Emblem Corp EMMBF

Healthcare Biotechnology Cannabis
"Emblem Corp is a licensed producer of medical cannabis. It is intended to cultivate and cure cannabis for medicinal use. The group operates in the business segment of production and sale of medical cannabis."


OTCPK:EMMBF - Post by User

Emblem Corp > New CEO start tomorrow?
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(1)
•••
Comment by PruneFaceon Nov 30, 2017 8:20pm
99 Views
Post# 27068635

RE:New CEO start tomorrow?

RE:New CEO start tomorrow?
albatrosstrader wrote: I hope he makes a grande entrance. EMC has been the most frustrating stock in the entire sector. Drops hard on bad days doesnt move on good days.  


Definitely the laggard in the sector. I still have my warrants from the IPO. A person would almost have to think that at some point a company would value what they have, which is mainly the license, clients and the pharma applications. Capacity is not that significant. The warrants could be worth the gamble given their longer term to expiry. Hopefully the new blood will add some excitement. AIMO.
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities